ultrasound probe disinfection market

Global Ultrasound Probe Disinfection Market - Industry Trends and Forecast to 2029

  • Published Date: 2022-11-22
  • Report ID: 144207
  • Pages: 200
  • Format: prudent report format


Short Description
Global Ultrasound Probe Disinfection Market, By Products & Services (Instruments, Consumables, and Services), Level of Disinfection (Low Level Disinfection, Intermediate Level Disinfection, and High Level Disinfection), Type of Probe (Critical Devices, Noncritical Devices, and Semicritical Devices), End User (Hospitals & Diagnostic Imaging Centers, Ambulatory Care Centers, Maternity Centers, Academic & Research Institutes, and Others), Distribution Channel (Direct Tender, Third Party Distributors, and Others), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey and rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific, Brazil and Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, and Rest of the Middle East and Africa), Industry Trends and Forecast to 2029

Market Definition:
Disinfection refers to the thermal or chemical destruction of pathogenic and other types of microorganisms. The process is less lethal than sterilization, as disinfection destroys the most recognized pathogenic microorganism. According to the American Institute of Ultrasound in Medicine (AIUM), "infection control is an integral part for safe and effective use of ultrasound in medicine."
There are different types and categories of disinfectants such as low-level disinfectants, which destroy most bacteria excluding Tubercle bacilli, some fungi, and some viruses; intermediate level disinfectants which destroy vegetative bacteria including Tubercle bacilli and many viruses, but not bacterial spores; and high-level disinfectants which remove bacterial spores when utilized in adequate concentrations and appropriate conditions. The disinfection of the ultrasound probe by manually soaking it in the antiseptic solution is a standard procedure maintained in healthcare facilities.
Market Segmentation:
The global ultrasound probe disinfection market is categorized into five notable segments which are based on products & services, level of disinfection, type of probe, end user, and distribution channel.
On the basis of products & services, the global ultrasound probe disinfection market is further segmented into instruments, consumables, and services

On the basis of the level of disinfection, the global ultrasound probe disinfection market is segmented into low level disinfection, intermediate level disinfection, and high level disinfection

On the basis of the type of probe, the global ultrasound probe disinfection market is segmented into critical devices, noncritical devices, and semicritical devices

On the basis of end user, the global ultrasound probe disinfection market is segmented into hospitals & diagnostic imaging centers, ambulatory care centers, maternity centers, academic & research institutes, and others

On the basis of distribution channel, the global ultrasound probe disinfection market is segmented into direct tender, third party distributors, and others

Market Players

Some of the key market players for global ultrasound probe disinfection market are listed below:

General Electric Company
STERIS
CS Medical LLC
Nanosonics
Ecolab
VIROX TECHNOLOGIES, INC.
Germitec
ASP
Schlke & Mayr GmbH
Parker Laboratories, Inc.
Metrex Research, LLC
Siemens Healthcare GmbH
MediSound
API 2000
BODE Chemie GmbH
IMA-X
Medevice Healthtech
FUJIFILM Healthcare Europe (A subsidiary of FUJIFILM Corporation)
Whiteley
Soluscope
LANXESS
Borer Chemie AG
Tristel Plc
PDI, Inc.
Pharmaceutical Innovations, Inc.
CIVCO Medical Solutions
AUS TULSA
MH HEALTHCARE CO., LTD


TABLE OF CONTENTS
1 INTRODUCTION 45
1.1 OBJECTIVES OF THE STUDY 45
1.2 MARKET DEFINITION 45
1.3 OVERVIEW OF GLOBAL ULTRASOUND PROBE DISINFECTION MARKET 45
1.4 LIMITATIONS 47
1.5 MARKETS COVERED 47
2 MARKET SEGMENTATION 50
2.1 MARKETS COVERED 50
2.2 GEOGRAPHICAL SCOPE 51
2.3 YEARS CONSIDERED FOR THE STUDY 52
2.4 CURRENCY AND PRICING 52
2.5 DBMR TRIPOD DATA VALIDATION MODEL 53
2.6 MULTIVARIATE MODELLING 56
2.7 PRODUCTS & SERVICES LIFELINE CURVE 56
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 57
2.9 DBMR MARKET POSITION GRID 58
2.10 MARKET END USER COVERAGE GRID 60
2.11 VENDOR SHARE ANALYSIS 61
2.12 SECONDARY SOURCES 62
2.13 ASSUMPTIONS 62
3 EXECUTIVE SUMMARY 63
4 PREMIUM INSIGHTS 65
4.1 PESTEL ANALYSIS 66
4.2 PORTERS FIVE FORCES 67
5 REGULATORY FRAMEWORK 70
6 MARKET OVERVIEW 72
6.1 DRIVERS 74
6.1.1 HIGH PREVALENCE OF HOSPITAL-ACQUIRED INFECTIONS (HAI'S) 74
6.1.2 RISE IN AWARENESS REGARDING USE OF REPROCESSED EQUIPMENT 74
6.1.3 INCREASE IN CHRONIC AND CONTAGIOUS DISEASES 75
6.1.4 TECHNOLOGICAL ADVANCEMENTS 76
6.2 RESTRAINTS 76
6.2.1 SIDE EFFECTS OF USING DISINFECTANT WIPES 76
6.2.2 RELUCTANCE TOWARDS SHIFT FROM MANUAL DISINFECTION METHODS TO AUTOMATED PROBE RE-PROCESSORS 77
6.3 OPPORTUNITIES 77
6.3.1 GROWTH IN BIRTH RATES/NUMBER OF PREGNANCIES 77
6.3.2 INCREASE IN USE OF HIGH-LEVEL DISINFECTION SYSTEMS 78
6.4 CHALLENGES 78
6.4.1 LESS STORAGE FOR ULTRASOUND PROBE CABINETS 78
6.4.2 HIGH COST OF AUTOMATED PROBE RE-PROCESSORS 79
7 IMPACT OF COVID-19 ON THE GLOBAL ULTRASOUND PROBE DISINFECTION MARKET 80
7.1 IMPACT ON PRICE 80
7.2 IMPACT ON DEMAND 80
7.3 IMPACT ON SUPPLY CHAIN 81
7.4 STRATEGIC DECISIONS BY MANUFACTURERS 81
7.5 CONCLUSION 82
8 GLOBAL ULTRASOUND PROBE DISINFECTION MARKET, BY PRODUCTS & SERVICES 83
8.1 OVERVIEW 84
8.2 INSTRUMENTS 87
8.2.1 REPROCESSORS 88
8.2.1.1 AUTOMATED REPROCESSORS 88
8.2.1.2 MANUAL REPROCESSORS 88
8.2.2 ULTRASOUND TRANSDUCER STORAGE CABINETS 88
8.2.3 UV-C DISINFECTORS 89
8.2.4 OTHERS 89
8.3 CONSUMABLES 89
8.3.1 DISINFECTANTS 90
8.3.1.1 DISINFECTANTS WIPES 91
8.3.1.2 DISINFECTANTS LIQUID 91
8.3.1.3 DISINFECTANTS SPRAYS 91
8.3.1.4 HIGH-LEVEL DISINFECTANTS 91
8.3.1.5 INTERMEDIATE LEVEL DISINFECTION 91
8.3.1.6 LOW-LEVEL DISINFECTANTS 91
8.3.2 DETERGENTS 92
8.3.2.1 ENZYMATIC 92
8.3.2.2 NON-ENZYMATIC 92
8.4 SERVICES 92
9 GLOBAL ULTRASOUND PROBE DISINFECTION MARKET, BY LEVEL OF DISINFECTION 94
9.1 OVERVIEW 95
9.2 HIGH-LEVEL DISINFECTANTS 98
9.3 INTERMEDIATE LEVEL DISINFECTION 98
9.4 LOW-LEVEL DISINFECTANTS 99
10 GLOBAL ULTRASOUND PROBE DISINFECTION MARKET, BY TYPE OF PROBE 100
10.1 OVERVIEW 101
10.2 CRITICAL DEVICES 104
10.2.1 INTRACARDIAC ULTRASOUND PROBES 104
10.2.2 OTHERS 105
10.3 NONCRITICAL DEVICES 105
10.3.1 LINEAR TRANSDUCERS 106
10.3.2 CONVEX TRANSDUCERS 106
10.3.3 PHASED ARRAY TRANSDUCERS 106
10.4 SEMICRITICAL DEVICES 106
10.4.1 ENDOCAVITARY TRANSDUCERS 107
10.4.2 TRANSESOPHAGEAL PROBES 107
11 GLOBAL ULTRASOUND PROBE DISINFECTION MARKET, BY END USER 108
11.1 OVERVIEW 109
11.2 HOSPITALS & DIAGNOSTIC IMAGING CENTERS 112
11.3 AMBULATORY CARE CENTERS 112
11.4 MATERNITY CENTERS 113
11.5 ACADEMIC & RESEARCH INSTITUTES 114
11.6 OTHERS 114
12 GLOBAL ULTRASOUND PROBE DISINFECTION MARKET, BY DISTRIBUTION CHANNEL 116
12.1 OVERVIEW 117
5.1 DIRECT TENDER 120
12.2 THIRD PARTY DISTRIBUTORS 120
12.3 OTHERS 121
13 GLOBAL ULTRASOUND PROBE DISINFECTION MARKET, BY REGION 122
13.1 OVERVIEW 123
13.2 NORTH AMERICA 128
13.2.1 U.S. 136
13.2.2 CANADA 140
13.2.3 MEXICO 144
13.3 EUROPE 148
13.3.1 GERMANY 157
13.3.2 FRANCE 161
13.3.3 U.K. 165
13.3.4 ITALY 169
13.3.5 SPAIN 173
13.3.6 NETHERLANDS 177
13.3.7 DENMARK 181
13.3.8 SWITZERLAND 185
13.3.9 AUSTRIA 189
13.3.10 NORWAY 193
13.3.11 HUNGARY 197
13.3.12 GREECE 201
13.3.13 LITHUANIA 205
13.3.14 IRELAND 209
13.3.15 POLAND 213
13.3.16 REST OF EUROPE 217
13.4 ASIA-PACIFIC 218
13.4.1 CHINA 227
13.4.2 JAPAN 231
13.4.3 INDIA 235
13.4.4 SOUTH KOREA 239
13.4.5 AUSTRALIA 243
13.4.6 SINGAPORE 247
13.4.7 THAILAND 251
13.4.8 MALAYSIA 255
13.4.9 INDONESIA 259
13.4.10 PHILIPPINES 263
13.4.11 REST OF ASIA-PACIFIC 267
13.5 SOUTH AMERICA 268
13.5.1 BRAZIL 277
13.5.2 ARGENTINA 281
13.5.3 PERU 285
13.5.4 REST OF SOUTH AMERICA 289
13.6 MIDDLE EAST AND AFRICA 290
13.6.1 SOUTH AFRICA 299
13.6.2 SAUDI ARABIA 303
13.6.3 U.A.E. 307
13.6.4 EGYPT 311
13.6.5 KUWAIT 315
13.6.6 ISRAEL 319
13.6.7 REST OF MIDDLE EAST AND AFRICA 323
14 GLOBAL ULTRASOUND PROBE DISINFECTION MARKET: COMPANY LANDSCAPE 324
14.1 COMPANY SHARE ANALYSIS: GLOBAL 324
14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 325
14.3 COMPANY SHARE ANALYSIS: EUROPE 326
14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 327
15 SWOT ANALYSIS 328
16 COMPANY PROFILE 329
16.1 ECOLAB 329
16.1.1 COMPANY SNAPSHOT 329
16.1.2 REVENUE ANALYSIS 329
16.1.3 COMPANY SHARE ANALYSIS 330
16.1.4 PRODUCT PORTFOLIO 330
16.1.5 RECENT DEVELOPMENTS 330
16.2 NANOSONICS 331
16.2.1 COMPANY SNAPSHOT 331
16.2.2 REVENUE ANALYSIS 331
16.2.3 COMPANY SHARE ANALYSIS 332
16.2.4 PRODUCT PORTFOLIO 332
16.2.5 RECENT DEVELOPMENT 332
16.3 ASP 333
16.3.1 COMPANY SNAPSHOT 333
16.3.2 COMPANY SHARE ANALYSIS 333
16.3.3 PRODUCT PORTFOLIO 334
16.3.4 RECENT DEVELOPMENT 334
16.4 SCHULKE & MAYR GMBH 335
16.4.1 COMPANY SNAPSHOT 335
16.4.2 COMPANY SHARE ANALYSIS 335
16.4.3 PRODUCT PORTFOLIO 335
16.4.4 RECENT DEVELOPMENT 335
16.5 GENERAL ELECTRIC COMPANY 336
16.5.1 COMPANY SNAPSHOT 336
16.5.2 REVENUE ANALYSIS 336
16.5.3 COMPANY SHARE ANALYSIS 337
16.5.4 PRODUCT PORTFOLIO 337
16.5.5 RECENT DEVELOPMENTS 337
16.6 CIVCO MEDICAL SOLUTIONS 338
16.6.1 COMPANY SNAPSHOT 338
16.6.2 PRODUCT PORTFOLIO 338
16.6.3 RECENT DEVELOPMENT 338
16.7 API 2000 339
16.7.1 COMPANY SNAPSHOT 339
16.7.2 PRODUCT PORTFOLIO 339
16.7.3 RECENT DEVELOPMENT 339
16.8 AUS TULSA 340
16.8.1 COMPANY SNAPSHOT 340
16.8.2 PRODUCT PORTFOLIO 340
16.8.3 RECENT DEVELOPMENTS 340
16.9 BODE CHEMIE GMBH 342
16.9.1 COMPANY SNAPSHOT 342
16.9.2 PRODUCT PORTFOLIO 342
16.9.3 RECENT DEVELOPMENT 342
16.10 BORER CHEMIE AG 343
16.10.1 COMPANY SNAPSHOT 343
16.10.2 PRODUCT PORTFOLIO 343
16.10.3 RECENT DEVELOPMENT 343
16.11 CS MEDICAL LLC 344
16.11.1 COMPANY SNAPSHOT 344
16.11.2 PRODUCT PORTFOLIO 344
16.11.3 RECENT DEVELOPMENT 345
16.12 FUJIFILM HEALTHCARE EUROPE (A SUBSIDIARY OF FUJIFILM CORPORATION) 346
16.12.1 COMPANY SNAPSHOT 346
16.12.2 REVENUE ANALYSIS 346
16.12.3 PRODUCT PORTFOLIO 347
16.12.4 RECENT DEVELOPMENT 347
16.13 GERMITEC 348
16.13.1 COMPANY SNAPSHOT 348
16.13.2 PRODUCT PORTFOLIO 348
16.13.3 RECENT DEVELOPMENT 348
16.14 IMA-X 349
16.14.1 COMPANY SNAPSHOT 349
16.14.2 PRODUCT PORTFOLIO 349
16.14.3 RECENT DEVELOPMENT 350
16.15 LANXESS 351
16.15.1 COMPANY SNAPSHOT 351
16.15.2 REVENUE ANALYSIS 351
16.15.3 PRODUCT PORTFOLIO 352
16.15.4 RECENT DEVELOPMENTS 352
16.16 MEDEVICE HEALTHTECH 353
16.16.1 COMPANY SNAPSHOT 353
16.16.2 PRODUCT PORTFOLIO 353
16.16.3 RECENT DEVELOPMENT 353
16.17 MEDISOUND 354
16.17.1 COMPANY SNAPSHOT 354
16.17.2 PRODUCT PORTFOLIO 354
16.17.3 RECENT DEVELOPMENT 354
16.18 MH HEALTHCARE CO., LTD. 355
16.18.1 COMPANY SNAPSHOT 355
16.18.2 PRODUCT PORTFOLIO 355
16.18.3 RECENT DEVELOPMENT 355
16.19 METREX RESEARCH, LLC 356
16.19.1 COMPANY SNAPSHOT 356
16.19.2 PRODUCT PORTFOLIO 356
16.19.3 RECENT DEVELOPMENTS 356
16.20 PARKER LABORATORIES, INC. 358
16.20.1 COMPANY SNAPSHOT 358
16.20.2 PRODUCT PORTFOLIO 358
16.20.3 RECENT DEVELOPMENT 358
16.21 PDI, INC. 359
16.21.1 COMPANY SNAPSHOT 359
16.21.2 PRODUCT PORTFOLIO 359
16.21.3 RECENT DEVELOPMENTS 359
16.22 PHARMACEUTICAL INNOVATIONS, INC. 360
16.22.1 COMPANY SNAPSHOT 360
16.22.2 PRODUCT PORTFOLIO 360
16.22.3 RECENT DEVELOPMENT 360
16.23 SIEMENS HEALTHCARE GMBH 361
16.23.1 COMPANY SNAPSHOT 361
16.23.2 REVENUE ANALYSIS 361
16.23.3 PRODUCT PORTFOLIO 362
16.23.4 RECENT DEVELOPMENT 362
16.24 SOLUSCOPE 363
16.24.1 COMPANY SNAPSHOT 363
16.24.2 PRODUCT PORTFOLIO 363
16.24.3 RECENT DEVELOPMENT 363
16.25 STERIS 364
16.25.1 COMPANY SNAPSHOT 364
16.25.2 REVENUE ANALYSIS 364
16.25.3 PRODUCT PORTFOLIO 365
16.25.4 RECENT DEVELOPMENT 365
16.26 TRISTEL PLC 366
16.26.1 COMPANY SNAPSHOT 366
16.26.2 PRODUCT PORTFOLIO 366
16.26.3 RECENT DEVELOPMENT 366
16.27 VIROX TECHNOLOGIES INC. 367
16.27.1 COMPANY SNAPSHOT 367
16.27.2 PRODUCT PORTFOLIO 367
16.27.3 RECENT DEVELOPMENTS 367
16.28 WHITELEY 368
16.28.1 COMPANY SNAPSHOT 368
16.28.2 PRODUCT PORTFOLIO 368
16.28.3 RECENT DEVELOPMENT 368
17 QUESTIONNAIRE 369
18 RELATED REPORTS 372

CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.